The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

A new blood test could detect lung cancer recurrence months before it appears on scans, potentially enabling earlier ...

A prospective study found that a multicancer blood test detected signals across 17 cancer types with 99.64% specificity, but ...

Abbott’s next-gen Oncodetect molecular residual disease (MRD) test detects traces of circulating tumor DNA in a patient’s ...

New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...

For many people with cancer, completing treatment can bring a new uncertainty: Is my cancer really gone? Even after treatment, small amounts of cancer may remain in the body at levels that can be ...

At the Big Ten CRC Summit, VK Gadi, MD, PhD, explained why functional drug testing and genomic profiling should be used ...

Lynch syndrome is a symptomless genetic condition that increases the risk of developing multiple cancers. 95% of Americans ...

Despite being one of the deadliest cancers, pancreatic screening carries more risks than benefits for average-risk patients, ...

Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients with solid tumors ...

Friends may play a direct role in whether people keep up with cancer screening regularly, while family influence appears to operate more through knowledge and attitudes towards screening, according to ...